(EN)
The present invention relates to pharmaceutical compositions having antiviral activity against Coronavirus, and more particularly against those viruses responsible for Severe Acute Respiratory Syndrome (SARS). In a preferred embodiment it comprises a total standardised extract of a Scutellariae spp.
(ZH) 本发明涉及药物组合物,其具有抗冠状病毒,并且更特别是抗引起严重急性呼吸器官综合征(SARS)的那些病毒的抗病毒活性。在一个优选的实施方案中,它含有黄芩属种(Scutellariae spp)的总标准化提取物。